If you need more lookups,
subscriptions start at $34 USD/month.
Kevin Kwei Location
California, United States
Kevin Kwei Work
2023 -now Head of Translational Medicine, Clin Pharm and Bioanalytical @
2022 -2023 Biomarker Consultant @
2022 -2022 VP, Biomarker and Translational Research @
2021 -2022 Senior Director, Biomarker Sciences @
2017 -2021 Director, Translational Medicine @
2016 -2017 Senior Scientist, Clinical Genetics @
2014 -2015 Manager, Oncology Biomarker @
2012 -2014 Scientist II, Translational Genomics @
2011 -2012 Associate Scientist @
2011 -2011 Scientist @
2010 -2011 Research Scientist @
2005 -2010 Postdoctoral Fellow @
Kevin Kwei Education
University of Arizona
PhD (Cancer Biology)
1998-2004
University of Wisconsin-Madison
B.S (Molecular Biology)
1992-1996
St. Paul's Co-educational College
(Duke of Edinburgh -Silver Award)
Kevin Kwei Skills
Cancer
Genetics
Assay Development
Cell
Biomarkers
High Throughput Screening
Proteomics
Biomarker Discovery
qPCR
Molecular Biology
PCR
Cell Culture
DNA sequencing
Genomics
Biochemistry
Sequencing
In Vitro
In Vivo
Translational Medicine
RNAi
Laboratory
Cancer Research
Microarray Analysis
Cell Biology
Oncology
Healthcare
Protocol
Microsoft Word
High Throughput
Microsoft Excel
Phase Iii
Design
Research
Kevin Kwei Summary
Kevin Kwei, based in California, United States, is currently a Head of Translational Medicine, Clin Pharm and Bioanalytical at FibroGen, Inc.. Kevin Kwei brings experience from previous roles at Annexon Biosciences, Kartos Therapeutics, Inc., Biosplice Therapeutics and Pharmacyclics, an AbbVie Company. Kevin Kwei holds a 1998 - 2004 PhD in Cancer Biology @ University of Arizona. With a robust skill set that includes Cancer, Genetics, Assay Development, Cell, Biomarkers and more. Kevin Kwei has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Kevin Kwei?
Find contact details for 700 million professionals.